title: JNC 8: what's covered, what's not, and what else to consider.
abstract: JNC 8 guidelines offer greater discretion in drug choice and modest relaxation of some BP targets. This review summarizes the recommendations and provides guidance on 2 patient populations that aren't addressed.
authors.affiliation: University of Wyoming, School of Pharmacy, Laramie, WY, USA. Email: tbaher@uwyo.edu.
authors.forename: Tracy D
authors.initials: TD
authors.lastname: Mahvan
authors.forename: Steven G
authors.initials: SG
authors.lastname: Mlodinow
mesh_terms: D000328:Adult; D000367:Age Factors; D000959:Antihypertensive Agents / Q000145:classification / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination / Q000379:methods / Q000592:standards; D018660:Blood Pressure Monitoring, Ambulatory / Q000379:methods; D015897:Comorbidity; D003327:Coronary Disease / Q000517:prevention & control*; D005006:Ethnicity; D055317:Evidence-Based Practice / Q000379:methods / Q000458:organization & administration; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000208:ethnology / Q000523:psychology; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D040242:Risk Reduction Behavior; D020521:Stroke / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents